Get the Skinny on Bimekizumab in PsA
Dr. Janet Pope discusses abstract presented at ACR22 Convergence in Philadelphia, PA.
L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Low dose steroids can negatively impact bone healthDr. Janet Pope discusses abstract L01 presented at ACR22 Convergence in Philadelphia, PA.
L01: Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study
The First Head to Head trial in Axial Spondyloarthritis
Dr. Lianne Gensler discusses abstract L15 presented at ACR22 Convergence in Philadelphia, PA.
L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study
Why Clinical Trials?
Dr. Guillermo Valenzuela talks about the importance of clinical trials from ACR22 Convergence in Philadelphia, PA.
JAK-TYK2 Topic Panel
SpA Topic Panel
Rheumatoid Arthritis Topic Panel
Psoriatic Arthritis Topic Panel
Daily Recap - WEDNESDAY
Lupus Topic Panel
ACR 2023 Podcast - Day3D
ACR 2023 Podcast - Day3C
ACR 2023 Daily Recap Panel - TUESDAY
ACR 2023 Podcast - Day3B
ACR 2023 Podcast - Day3A
ACR 2023 Podcast - Day2B
ACR 2023 Podcast - Day2A
ACR 2023 Daily Recap - MONDAY
ACR 2023 Daily Recap Panel - Day 1
ACR Podcast - Day1B
ACR Podcast - Day1A
ACR Convergence Preview (11.10.2023)
ACR QD Clinics
Late Should Not Be Less (11.3.2023)
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive